Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China · Delayed Price · Currency is CNY 73.23
+1.18 (1.64%)
Sep 8, 2025, 2:45 PM CST
SHE:300573 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 503.57 | 338.06 | 240.04 | 211.68 | 194.7 | 87.98 | Upgrade |
Depreciation & Amortization | 99.83 | 99.92 | 88.81 | 74.37 | 67.28 | 45.51 | Upgrade |
Other Amortization | 6.87 | 6.58 | 4.53 | 5.65 | 6.21 | 3.35 | Upgrade |
Loss (Gain) From Sale of Assets | 1.06 | 0.98 | 0.04 | -0.42 | -5.16 | 0.08 | Upgrade |
Asset Writedown & Restructuring Costs | 14.05 | 14.05 | - | 0 | 0 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | -3.14 | - | Upgrade |
Provision & Write-off of Bad Debts | 0.41 | 3.32 | 3.03 | 0.93 | -0.19 | 1.04 | Upgrade |
Other Operating Activities | 19.1 | 10.54 | 10.23 | 5.53 | 24.49 | 14.32 | Upgrade |
Change in Accounts Receivable | -111.78 | -144.42 | -104.38 | -37.51 | -33.43 | -61.27 | Upgrade |
Change in Inventory | -36.43 | -20.99 | -22.05 | -34.35 | -27.8 | 8.71 | Upgrade |
Change in Accounts Payable | 27.45 | 95.54 | 73.17 | 23.51 | 73.27 | 18.72 | Upgrade |
Change in Other Net Operating Assets | 7.17 | 11.55 | 23.42 | 42.47 | 13.31 | 4.19 | Upgrade |
Operating Cash Flow | 535.79 | 416.98 | 317.57 | 286.26 | 306.96 | 122.16 | Upgrade |
Operating Cash Flow Growth | 33.81% | 31.30% | 10.94% | -6.74% | 151.28% | 64.90% | Upgrade |
Capital Expenditures | -215.84 | -198.71 | -261.96 | -299.23 | -95.06 | -108.15 | Upgrade |
Sale of Property, Plant & Equipment | 0.37 | 0.33 | 0.02 | 0.08 | 19.03 | 0 | Upgrade |
Divestitures | - | - | - | - | 1.26 | - | Upgrade |
Investment in Securities | - | -10 | - | - | -130.24 | - | Upgrade |
Other Investing Activities | -7.28 | -7.28 | - | - | 3 | - | Upgrade |
Investing Cash Flow | -222.75 | -215.67 | -261.94 | -299.15 | -202.01 | -108.15 | Upgrade |
Short-Term Debt Issued | - | 310 | 70 | 20 | 100 | 120 | Upgrade |
Total Debt Issued | 230 | 310 | 70 | 20 | 100 | 120 | Upgrade |
Short-Term Debt Repaid | - | -180 | - | -120 | -80 | -130 | Upgrade |
Long-Term Debt Repaid | - | -8.93 | -7.67 | -6.17 | -8.7 | - | Upgrade |
Total Debt Repaid | -320.9 | -188.93 | -7.67 | -126.17 | -88.7 | -130 | Upgrade |
Net Debt Issued (Repaid) | -90.9 | 121.07 | 62.33 | -106.17 | 11.3 | -10 | Upgrade |
Issuance of Common Stock | 22.17 | 22.17 | 25.3 | 27.56 | 580.18 | - | Upgrade |
Repurchase of Common Stock | -22.15 | -0.32 | -16.81 | - | -0.27 | -0.54 | Upgrade |
Common Dividends Paid | -268.78 | -466.57 | -178.49 | -80.84 | -47.13 | -16.2 | Upgrade |
Other Financing Activities | 29.4 | 4.87 | 23.5 | 1.02 | -5.95 | 11.66 | Upgrade |
Financing Cash Flow | -330.26 | -318.79 | -84.17 | -158.42 | 538.12 | -15.08 | Upgrade |
Foreign Exchange Rate Adjustments | -1.74 | -0.11 | 0.2 | -0.09 | -0.13 | -0.02 | Upgrade |
Net Cash Flow | -18.95 | -117.58 | -28.34 | -171.4 | 642.94 | -1.09 | Upgrade |
Free Cash Flow | 319.96 | 218.27 | 55.61 | -12.96 | 211.9 | 14.01 | Upgrade |
Free Cash Flow Growth | 51.67% | 292.54% | - | - | 1412.86% | 241.17% | Upgrade |
Free Cash Flow Margin | 14.45% | 11.23% | 3.79% | -1.04% | 20.61% | 2.03% | Upgrade |
Free Cash Flow Per Share | 1.30 | 0.89 | 0.23 | -0.05 | 0.94 | 0.06 | Upgrade |
Cash Income Tax Paid | 294.65 | 215.15 | 109.68 | 134.28 | 103.23 | 73.86 | Upgrade |
Levered Free Cash Flow | 272.15 | 207.85 | -22.52 | -104.31 | 127.3 | -12.51 | Upgrade |
Unlevered Free Cash Flow | 276.06 | 211.42 | -21.62 | -103.72 | 131.04 | -8.8 | Upgrade |
Change in Working Capital | -109.1 | -56.47 | -29.11 | -11.49 | 22.76 | -30.12 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.